Insmed (NASDAQ: INSM) has consistently outperformed the market over the past decade with an annualized return of 28.23%, exceeding the market average by 14.72%. The company’s current market capitalization stands at approximately $31.14 billion. For investors, a $1,000 investment in Insmed’s stock a decade ago would now be valued at $11,283.36, given the stock price of $146.00 at the time of this writing.
The significant takeaway from Insmed’s performance illustrates the power of compounded returns in capital growth over time. This highlights the potential benefits of long-term investing strategies, especially in a robust financial environment.
Why this story matters
Key takeaway
Opposing viewpoint
